Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 4 Grant or award SVP, CFO, CBO & Treasurer acquired 194,900 shares (grant or award)
  2. 4 Exercise or conversion Director acquired 20,100 shares (option exercise)
  3. 4 Grant or award SVP, CFO, CBO & Treasurer acquired 350,000 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Grant or award Director acquired 30,000 shares (grant or award)
  6. 4 Grant or award Director acquired 30,000 shares (grant or award)
  7. 4 Grant or award Director acquired 30,000 shares (grant or award)
  8. 4 Grant or award Director acquired 30,000 shares (grant or award)
  9. 4 Grant or award Director acquired 30,000 shares (grant or award)
  10. 4 Grant or award Director acquired 30,000 shares (grant or award)
  11. 4 Grant or award Director acquired 30,000 shares (grant or award)
  12. 4 Planned sale SVP, Chief Legal Officer sold 12,016 shares at $1.26 ($15,140)
  13. 4 Planned sale SVP, Chief Operating Officer sold 34,840 shares at $1.26 ($43,898)
  14. 4 Open-market sale SVP, Chief Medical Officer sold 27,000 shares at $1.15 ($31,050)
  15. 4 Open-market sale SVP, Chief Operating Officer sold 8,661 shares at $1.58 ($13,684)
  16. 4 Open-market sale SVP, Chief Legal Officer sold 5,974 shares at $1.58 ($9,439)
  17. 4 Open-market sale CEO and President sold 46,570 shares at $1.58 ($73,581)
  18. 4 Open-market sale SVP, Chief Medical Officer sold 7,169 shares at $1.58 ($11,327)
  19. 4 Planned sale SVP, Chief Legal Officer sold 7,411 shares at $1.52 ($11,265)
  20. 4 Open-market sale SVP, Chief Operating Officer sold 10,744 shares at $1.52 ($16,331)

Page 3 of 19 · 378 filings